- Home
- ASG vs HRTX Comparison
ASG vs HRTX Comparison
Compare ASG & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASG
- HRTX
- Stock Information
- Founded
- ASG 1986
- HRTX 1983
- Country
- ASG United States
- HRTX United States
- Employees
- ASG N/A
- HRTX N/A
- Industry
- ASG Investment Managers
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- ASG Finance
- HRTX Health Care
- Exchange
- ASG Nasdaq
- HRTX Nasdaq
- Market Cap
- ASG 295.0M
- HRTX 325.0M
- IPO Year
- ASG N/A
- HRTX 1987
- Fundamental
- Price
- ASG $5.24
- HRTX $1.93
- Analyst Decision
- ASG
- HRTX Strong Buy
- Analyst Count
- ASG 0
- HRTX 2
- Target Price
- ASG N/A
- HRTX $5.50
- AVG Volume (30 Days)
- ASG 324.3K
- HRTX 2.0M
- Earning Date
- ASG 01-01-0001
- HRTX 05-06-2025
- Dividend Yield
- ASG 8.09%
- HRTX N/A
- EPS Growth
- ASG N/A
- HRTX N/A
- EPS
- ASG N/A
- HRTX N/A
- Revenue
- ASG N/A
- HRTX $148,518,000.00
- Revenue This Year
- ASG N/A
- HRTX $12.60
- Revenue Next Year
- ASG N/A
- HRTX $13.66
- P/E Ratio
- ASG N/A
- HRTX N/A
- Revenue Growth
- ASG N/A
- HRTX 12.43
- 52 Week Low
- ASG $4.47
- HRTX $1.04
- 52 Week High
- ASG $5.71
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- ASG 58.65
- HRTX 47.02
- Support Level
- ASG $5.15
- HRTX $1.82
- Resistance Level
- ASG $5.29
- HRTX $1.93
- Average True Range (ATR)
- ASG 0.08
- HRTX 0.11
- MACD
- ASG -0.01
- HRTX 0.00
- Stochastic Oscillator
- ASG 70.59
- HRTX 62.16
About ASG Liberty All-Star Growth Fund Inc.
Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.